Xingping Qin

1.3k total citations
31 papers, 608 citations indexed

About

Xingping Qin is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Xingping Qin has authored 31 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Neurology and 5 papers in Genetics. Recurrent topics in Xingping Qin's work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Intracerebral and Subarachnoid Hemorrhage Research (5 papers) and Glioma Diagnosis and Treatment (3 papers). Xingping Qin is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Intracerebral and Subarachnoid Hemorrhage Research (5 papers) and Glioma Diagnosis and Treatment (3 papers). Xingping Qin collaborates with scholars based in China, United States and United Kingdom. Xingping Qin's co-authors include Renzhong Liu, Farhana Akter, Jing Cheng, Qi Wan, Zhihong Jian, Jun‐Chun Tang, Meng‐Xian Pan, Songfeng Chen, Long Lu and Ya Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Xingping Qin

29 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingping Qin China 16 243 154 80 77 75 31 608
Yukiya Suzuki Japan 12 183 0.8× 187 1.2× 142 1.8× 60 0.8× 122 1.6× 16 650
Gezhi Xu China 19 376 1.5× 176 1.1× 76 0.9× 51 0.7× 127 1.7× 77 1.1k
Li Lyu China 10 231 1.0× 61 0.4× 80 1.0× 80 1.0× 46 0.6× 17 741
Hanbin Wang China 15 228 0.9× 59 0.4× 92 1.1× 72 0.9× 80 1.1× 54 582
Nathalie Perek France 16 169 0.7× 108 0.7× 40 0.5× 60 0.8× 20 0.3× 42 656
Delu Song United States 22 397 1.6× 125 0.8× 78 1.0× 26 0.3× 130 1.7× 42 987
Souska Zandi Switzerland 23 440 1.8× 95 0.6× 57 0.7× 53 0.7× 118 1.6× 59 1.4k
Mansoor Nasim United States 13 178 0.7× 104 0.7× 49 0.6× 30 0.4× 50 0.7× 41 605
Yibo Liu China 15 178 0.7× 90 0.6× 122 1.5× 61 0.8× 64 0.9× 49 560
Caterina Visconte Italy 14 299 1.2× 130 0.8× 65 0.8× 139 1.8× 67 0.9× 25 653

Countries citing papers authored by Xingping Qin

Since Specialization
Citations

This map shows the geographic impact of Xingping Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingping Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingping Qin more than expected).

Fields of papers citing papers by Xingping Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingping Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingping Qin. The network helps show where Xingping Qin may publish in the future.

Co-authorship network of co-authors of Xingping Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Xingping Qin. A scholar is included among the top collaborators of Xingping Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingping Qin. Xingping Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santana-Codina, Naiara, Qijia Yu, Cláudia Campos, et al.. (2025). De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. Nature Communications. 16(1). 6987–6987. 1 indexed citations
2.
Qin, Xingping, Damir Khabibullin, Tiegang Han, et al.. (2025). BCL-xL dependency in chromophobe renal cell carcinoma. Cancer Gene Therapy. 32(10). 1133–1143.
3.
Navarro, Paula P., Xingping Qin, Sneha Rath, et al.. (2024). In situ architecture of Opa1-dependent mitochondrial cristae remodeling. The EMBO Journal. 43(3). 391–413. 27 indexed citations
4.
Matoba, Yusuke, Venkatesh Pooladanda, Maryam Azimi, et al.. (2024). Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma. British Journal of Cancer. 130(9). 1463–1476. 6 indexed citations
5.
Singh, Rumani, Zintis Inde, Cameron Fraser, et al.. (2023). Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX. Cancer Research. 83(20). 3442–3461. 8 indexed citations
6.
Sekar, G., Xingping Qin, Cristina D. Guibao, et al.. (2022). Small molecule SJ572946 activates BAK to initiate apoptosis. iScience. 25(10). 105064–105064. 9 indexed citations
7.
Spetz, Johan, Mary H.C. Florido, Cameron Fraser, et al.. (2022). Heightened apoptotic priming of vascular cells across tissues and life span predisposes them to cancer therapy–induced toxicities. Science Advances. 8(45). eabn6579–eabn6579. 11 indexed citations
8.
Fraser, Cameron, Johan Spetz, Xingping Qin, et al.. (2022). Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics. Nature Communications. 13(1). 5789–5789. 12 indexed citations
9.
Qiao, Haowen, et al.. (2021). Global Evolution of Skeletal Muscle Tissue Engineering: A Scientometric Research. Tissue Engineering Part C Methods. 27(9). 497–511. 1 indexed citations
10.
Qin, Xingping, Rui Liu, Farhana Akter, et al.. (2021). Peri-tumoral brain edema associated with glioblastoma correlates with tumor recurrence. Journal of Cancer. 12(7). 2073–2082. 22 indexed citations
11.
Akter, Farhana, et al.. (2021). Association between Angiotensin-Converting Enzyme- Insertion/Deletion Polymorphism and Diabetes Mellitus-2 in Saudi Population. Asian Pacific Journal of Cancer Prevention. 22(1). 119–123. 4 indexed citations
12.
Qin, Xingping, Farhana Akter, Jing Cheng, et al.. (2020). Adaptive Immunity Regulation and Cerebral Ischemia. Frontiers in Immunology. 11. 689–689. 41 indexed citations
13.
Yang, Xiuxiu, et al.. (2020). TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression. PROTOPLASMA. 257(3). 921–930. 22 indexed citations
14.
Akter, Farhana, et al.. (2020). The Pathophysiology of Degenerative Cervical Myelopathy and the Physiology of Recovery Following Decompression. Frontiers in Neuroscience. 14. 138–138. 40 indexed citations
15.
Qin, Xingping, Farhana Akter, Qiurong Xie, et al.. (2020). Dumbbell shaped craniorbital cavernous hemangioma. BMC Neurology. 20(1). 149–149.
16.
Qiao, Haowen, et al.. (2019). Mesenchymal stem cells inhibited the inflammation and oxidative stress in LPS-activated microglial cells through AMPK pathway. Journal of Neural Transmission. 126(12). 1589–1597. 6 indexed citations
17.
Liu, Rui, Jun‐Chun Tang, Meng‐Xian Pan, et al.. (2019). BpV(pic) confers neuroprotection by inhibiting M1 microglial polarization and MCP-1 expression in rat traumatic brain injury. Molecular Immunology. 112. 30–39. 22 indexed citations
18.
Qin, Xingping, et al.. (2018). Curcumin Inhibits Monocyte Chemoattractant Protein-1 Expression in TNF-α induced Astrocytes Through AMPK Pathway. Neurochemical Research. 43(4). 775–784. 16 indexed citations
19.
Liu, Rui, Jun‐Chun Tang, Meng‐Xian Pan, et al.. (2018). ERK 1/2 Activation Mediates the Neuroprotective Effect of BpV(pic) in Focal Cerebral Ischemia–Reperfusion Injury. Neurochemical Research. 43(7). 1424–1438. 37 indexed citations
20.
Tang, Hailin, Yiqun Hu, Xingping Qin, et al.. (2012). Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro. Journal of Gastroenterology and Hepatology. 27(8). 1395–1404. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026